orexigen therapeutics inc
(OREX:NASDAQ GS)
2013 SEC Filings - orexigen therapeutics inc (OREX)
2012 SEC Filings - orexigen therapeutics inc (OREX)
2011 SEC Filings - orexigen therapeutics inc (OREX)
2010 SEC Filings - orexigen therapeutics inc (OREX)

| Recently Viewed | |||
| OREX:US | $6.33 USD | -0.05 | |
| Company | Last | Change |
| Enzon Pharmaceuticals Inc | $1.70 USD | 0.00 |
| NeurogesX Inc | $0.01 USD | -0.0009 |
| Optimer Pharmaceuticals Inc | $14.33 USD | -0.11 |
| Synta Pharmaceuticals Corp | $3.88 USD | -0.12 |
| View Industry Companies | ||
Industry Analysis
OREX
Industry Average
| Valuation | OREX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 168.1x |
|
| Price/Book | 10.1x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 142.7x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.













